Molecular Targeting Technologies

Molecular Targeting Technologies is a biotech company developing diagnostic and therapeutic molecules for cancer and cardiovascular diseases. It provides treatments for gastroenteropancreatic neuroendocrine tumors, glioblastoma multiforme (GBM), and non-small-cell lung cancer (NSCLC). The company also supplies research reagents, manufactures and sells a portfolio of products based on fluorescence.